Lessons from Pasteur may help prevent the deadly relapse of Ebola in patients: Using contingency vaccination to avoid Ebola relapse in immune-privileged organs

Front Immunol. 2023 Mar 20:14:1060481. doi: 10.3389/fimmu.2023.1060481. eCollection 2023.
No abstract available

Keywords: Ebola Virus Disease (EVD); Ebola virus (EBOV); Filovirus; contingency vaccination; immune-privileged organ; neutralizing antibody (NAb); vaccine; virus relapse.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Viral
  • Ebolavirus*
  • Hemorrhagic Fever, Ebola* / prevention & control
  • Humans
  • Vaccination

Substances

  • Antibodies, Viral

Grants and funding

This work was supported by the National Natural Science Foundation of China (82172272, 82072268, 81871697) and a university supporting grant (no. 2021JSTS10).